LNAI
Lunai Bioworks Inc.
1W: +158.8%
1M: -17.3%
3M: -51.5%
YTD: -50.9%
$0.47
+0.08 (+21.69%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$8.3M
52W Range0.151-7.34
Volume80,377,260
Avg Volume10,467,757
Beta0.56
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODavid H. Weinstein
Employees29
SectorHealthcare
IndustryBiotechnology
IPO Date2025-09-30
Websiterenovarogroup.com
2080 Century Park East
Los Angeles, CA 90067
US
Los Angeles, CA 90067
US
305 918 1980
About Lunai Bioworks Inc.
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
Latest News
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
Recent Insider Trades
No insider trades found